Barake Francisca, Paccot Mélanie, Rivera Marcela, Neira Carolina, Reyes Viviana, Escobar María Cristina
Ministry of Health Santiago Chile Ministry of Health, Santiago, Chile.
University of Chile Santiago Chile University of Chile, Santiago, Chile.
Rev Panam Salud Publica. 2022 Sep 2;46:e126. doi: 10.26633/RPSP.2022.126. eCollection 2022.
Hypertension (arterial blood pressure ≥ 140/90 mmHg) is a risk factor for cardiovascular diseases, with the greatest burden of attributable deaths in Chile, having a national prevalence of 27.6%. In 2018, the implementation of HEARTS begun in primary health care centers of the Public Health System, with the aim of achieving increase in control rates, by raising the proportion of hypertensive individuals who meet blood pressure goals (< 140/90 mmHg for individuals 15-79 years old and of 150/90 mmHg for individuals 80 years and older), and thus contributing to reduce cardiovascular morbidity and mortality associated with this condition. This is a descriptive study that follows average treatment and control rates from the Public Health System between 2017-2021 obtained from health centers statistics reports during HEARTS implementation. Treatment and control rates remained at 57% and 39% respectively between 2017-2019. Between 2020 and 2021, in the context of the SARS-CoV-2 pandemic, treatment and control rates decreased very significantly, reaching 46% and 26%, respectively, in December 2021, even though the number of centers reporting the implementation of HEARTS increased from 227 to 387 in this same period. Prior to the pandemic, during the last quarter of 2019, a decrease in cardiovascular health controls was already observed as a result of social protests. In light of the results, the technical pillars of the HEARTS Initiative have an important role in helping to recover the population control rates reached in 2019 and increasing the speed to achieve better hypertension control rates.
高血压（动脉血压≥140/90 mmHg）是心血管疾病的一个危险因素，在智利，其导致的死亡负担最为严重，全国患病率为27.6%。2018年，公共卫生系统的初级保健中心开始实施HEARTS项目，目的是通过提高达到血压目标（15 - 79岁个体血压<140/90 mmHg，80岁及以上个体血压<150/90 mmHg）的高血压患者比例来提高控制率，从而有助于降低与此疾病相关的心血管发病率和死亡率。这是一项描述性研究，跟踪了2017 - 2021年公共卫生系统的平均治疗率和控制率，数据来自HEARTS项目实施期间健康中心的统计报告。2017 - 2019年期间，治疗率和控制率分别保持在57%和39%。在2020年至2021年期间，在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行的背景下，治疗率和控制率显著下降，到2021年12月分别降至46%和26%，尽管同期报告实施HEARTS项目的中心数量从227个增加到了387个。在大流行之前，2019年最后一个季度，由于社会抗议活动，心血管健康控制率已经出现下降。鉴于这些结果，HEARTS倡议的技术支柱在帮助恢复2019年达到的人群控制率以及提高实现更好高血压控制率的速度方面发挥着重要作用。
